2016-03-03T00:00:00.000-05:00
novel cellular targets,0.628125
clinical-stage biotechnology company,0.246573
cancer research,0.628125
GLOBE NEWSWIRE,0.239504
underlying mechanisms,-0.407177
clinical-stage company,-0.407177
oncology,0.246573
optimal patient population,0.628125
new therapeutics,0.220948
products,0.628125
molecular diagnostics,-0.407177
validated biomarkers,0.628125
unmet medical needs,0.246573
